Argus Reiterates Corteva Buy with $91 Target; Cramer Sidelines on CTVA
Sep 29, 2026, 12:55 PM EDT3 sourcesAI-analyzed
Why it may matterVerify against the original reporting
A formal Buy rating with a target provides a clear upside path from current levels (~$77.74) toward ~$91, subject to market momentum and fundamentals. Historical reactions to price-target upgrades often materialize within weeks, though execution risk remains if the broader market weakens.
AI summary
What happened, with direct paths to the underlying reporting
Argus Research reaffirmed Corteva (CTVA) as a Buy with a $91 target on Sept 18, presenting a near-term upside catalyst that could lift shares toward the target. Jim Cramer hasn’t weighed in on Corteva, leaving upside potential reliant on external analyst sentiment and future company news. The stock traded around $77.74, down 1% Monday amid broader market chatter about other high-growth and high-yield names.
Argus reiterates Corteva Buy with a $91 target on Sept 18. Cramer has not reviewed CTVA.
CTVA traded about $77.74, down 1% Monday, setting up potential upside if catalysts emerge.
Forgent Power Solutions posted a Q4 beat: EPS 0.25, sales $461.67M, up 94% YoY; 2027 guidance above estimates.
Symbotic and Polaris tones show mixed sentiment, illustrating broader market caution around high-growth or high-yield names.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Corteva completed the spin-off of its seed unit into Vylor (VYLR) on Oct 1, 2026, creating a pure-play crop protection company alongside a standalone seed business. VYLR’s standal…
Multiple U.S. states filed a lawsuit against Corteva and Vylor, alleging the seed spinoff was a fraudulent step to avoid tens of billions in legacy PFAS liabilities. The suit rais…
Corteva has announced its plan to separate into two publicly traded entities by Q4 2023. This corporate restructuring could enhance operational efficiency and provide distinct foc…
Corteva's performance in Phase 9 is under analysis due to its Cakra structure, suggesting potential stock trajectory changes. Investors may want to track these indicators for bett…
StockNews.AISignal intelligence